Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

NIH Postpones New Biosketch Format Requirement until May 25, 2015

The National Institutes of Health (NIH) recently announced that a new biosketch format will be required for all applications submitted for FY2016 funding, and will be required beginning May 25, 2015. Originally, the requirement was to go into effect beginning January 25, 2015, but in response to input from the research community, the mandatory change in format was postponed.

The NIH has been piloting a planned modification of the biosketch since June 2012. The new format increases the page limit from 4 to 5 pages and increases the number of peer-reviewed publications from 15 to 20. The new format allows investigators to include a link to a complete listing of their publications in SciENcv or My Bibliography.

Visit the NIH website under the heading “Additional Format Pages” to obtain templates for the new biosketch format: http://grants.nih.gov/grants/funding/424/index.htm.

Local Assistance Available with New Biosketch Formatting

Contact Kathy Blazer, Interim Director, Cleveland Health Sciences Library, (216-368-1361 or kcb2@case.edu) if interested in having Kathy conduct a departmental information session, or to answer individual questions.

Review the Health Sciences Library's slide presentation at: http://www.case.edu/chsl/library/NIHBiosketch.pptx.

 

CDC: Economic Studies of Immunization Policies and Practices

Funding Opportunity Number: RFA-IP-15-001

The purpose of this Funding Opportunity Announcement is to obtain economic information about vaccines and immunization policies, programs, and practices using economic and decision analyses and other appropriate methods. The results of these economic studies will be used to help inform policy and the development of effective interventions. Three studies will be conducted, including an analysis of the financial, economic, and epidemiologic relationships between vaccine-preventable infectious diseases and chronic diseases in adult populations, and the opportunity costs for immunization of failure to prevent chronic diseases. Study 1 may include, but need not be limited to influenza and pneumococcal diseases and diabetes. Study 2 will focus on an estimation of the costs of norovirus disease. Study three will involve an analysis of issues related to provider reimbursement for adult vaccination services.

Application Deadline: March 3, 2015

For more information visit the CDC’s Full Funding Opportunity Announcement.

 
Visits by Federal Law Enforcement Officers

Many federal law enforcement agencies have university liaison programs. If you receive a visit or other contact from a federal law enforcement officer, the CWRU Compliance Office reminds you to first request identification and then to immediately contact the CWRU Office of General Counsel, 368-4286. The Office of General Counsel will communicate directly with the agency to ensure that any inquiries are addressed completely and appropriately.

Questions? Contact Lisa Palazzo (368.5791) or Boyd Kumher (368.0833) in the CWRU Compliance Office.

 
New Facilities and Administrative (F&A) Rate for Use in Proposals

Negotiations with the Department of Health and Human Services (DHHS) regarding the University’s F&A rates have concluded. DHHS has approved a (3) three year F&A rate of 58.5% for CWRU, which is a 1.5 percentage point change from our previous rate of 57%. This rate will be effective through June 2016.

The new F&A rate should be used when preparing proposal budgets for awards with an anticipated start date of July 1, 2013 or after.

Read the full notice of this change at: https://ora.ra.cwru.edu/research/docs/2012.10.08_Facilities_and_Administrative_rate.pdf.

 
Case-Coulter Translational Research Partnership (CCTRP)

This is the fourth year of the second phase of the Case-Coulter Translational Research Partnership to support collaborative translational research projects that address unmet or poorly met clinical needs. The CCTRP seeks to reduce the market risk of promising new clinical products arising from the research programs of BME and other Case faculty. Successful projects will thus often focus on the development of prototype products, building relationships with companies, performing clinical feasibility studies, obtaining regulatory approval, and other activities that companies or business experts indicate are the essential last steps before a license can be negotiated or a startup launched. An overarching goal of the program is to foster research and development work likely leading to commercially relevant translational technologies within a three- to five-year horizon. Because the goals of all Coulter projects are to reduce market risk, all proposals are expected to reflect genuine business input, and all projects must include a “business advisor” as an important member of the decision making team.

Awards up to $200,000 will be considered if well justified.

Letter of Intent Deadline: February 13, 2015

For more information visit the BME website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.